alexa Detection Of Acute Hepatitis E And Seroprevalences In Germany With New RecomWell HEV In Comparison To Wantai HEV | 71125
ISSN: 2167-0889

Journal of Liver
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

CO-ORGANIZED EVENT: 5th World Congress on Hepatitis & Liver Diseases & 2nd International Conference on Pancreatic Cancer & Liver Diseases
August 10-12, 2017 London, UK

F Struck, T Lüttich, S Schulz, E Eyl, O Bocher and E Soutschek
Mikrogen GmbH, Germany
Posters & Accepted Abstracts: J Liver
DOI: 10.4172/2167-0889-C1-015
Abstract
Introduction: Being underdiagnosed for a long time, the hepatitis E virus (HEV) is now known to be endemic in Europe and often described as the most frequent viral cause for acute hepatitis. HEV ELISA test systems are used routinely as screening assays in serological diagnostics and for epidemiological studies. In this evaluation, the performance of the improved versions of recomWell HEV IgG, IgM, distributed since 06/2015, was compared to Wantai HEV IgG, IgM. Both brands represent the two most commonly used commercial HEV ELISA assays in Europe. Material & Methods: In order to detect seroprevalences in Germany, 200 sera from healthy blood donors (Bavarian Red Cross) have been analyzed with recomWell HEV IgG (new & previous version) and Wantai IgG. Diagnostic sensitivity of recomWell HEV IgM (new) and Wantai IgM was evaluated using 89 well-defined samples from patients with confirmed acute HEV infection. Subsequent follow-up samples from one PCR positive patient have been analyzed with both ELISA IgM assays. Diagnostic specificity of recomWell HEV IgM (new) and Wantai IgM was determined with a HEV panel consisting of 359 samples (200 sera from blood donors and 159 sera from patients with clinical suspicion of non-E-hepatitis confirmed as HIV, HCV, HAV, Parvovirus B19, EBV, or CMV positive). Results: Analysis of 200 German blood donors results in similar HEV seroprevalences for recomWell IgG (33%) and Wantai IgG (32%). The clear improvement in sensitivity is demonstrated by the comparison of the new (33%) and previous version (18.5%) of recomWell HEV IgG. With respect to diagnostic specificity, both recomWell IgG and Wantai IgG demonstrated a very good and comparable performance (data not shown). With 98.9% recomWell HEV IgM shows excellent diagnostic sensitivity. Only one serum from a total of 89 was not found positive, whereas Wantai HEV IgM missed 6 sera, reaching a sensitivity of 93.3%. Analysis of paired samples demonstrates that recomWell HEV IgM detects IgM specific antibodies over a long period starting at the end of the viremic phase. Interestingly, Wantai HEV IgM is not able to detect specific antibodies in any sample of this PCR positive individual. IgG seroconversion was confirmed (data not shown). Both test systems, recomWell HEV IgM and Wantai HEV IgM, show a convincing specificity. Only 5 from 359 sera were found positive by each assay, resulting in a diagnostic specificity of 98.6%. Conclusion: The new recomWell HEV IgG, IgM assays show an excellent performance. Diagnostic sensitivity for IgG antibodies is similar to Wantai HEV IgG, reflected by the determination of comparable seroprevalences for German blood donors. Achieving a diagnostic sensitivity of 98.9% recomWell, HEV IgM performs better compared to Wantai HEV IgM with 93.3% and is highly suitable for the detection of acute hepatitis E.
Biography

F Struck has an expertise in Serodiagnostics of Infectious Diseases for 20 years, and is employed as a Project Manager of Infections and Autoimmune Diseases at Mikrogen GmbH since 2008.

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version